SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (189)7/6/1997 11:01:00 AM
From: Frank Haims   of 10280
 
Does anyone know how the oxybutynin (sp) trial is going. This is a potential blockbuster. In preliminary testing Sepracaor has shown they have eliminated the vast bulk of side effects but have not talked
about efficacy. Has anyone any insight. Frank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext